Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    PR Mobile Headlines    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory    |    Private Branding
All Press Releases for September 19, 2008 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Hepatitis B Foundation Launches Community Initiatives with New Associate Director of Public Health
Dr. Gang Chen has been appointed as the new Associate Director for Public Health by the Hepatitis B Foundation headquartered in Doylestown, PA. 
x-small text small text medium text large text


    /24-7PressRelease/ - DOYLESTOWN, PA, September 19, 2008 - The Hepatitis B Foundation, a world-class nonprofit research organization headquartered in Doylestown, Pa., has appointed Gang Chen, Ph.D., as its new Associate Director for Public Health.

Dr. Chen will help lead the Foundation's new public health research initiatives in the U.S. and China which include rigorous epidemiological studies and community-based programs to advance the care of those affected by chronic hepatitis B.

"Dr. Chen's extensive public health experience in hepatitis B will help drive our efforts to address the needs among communities most affected by hepatitis B," said Joan Block, Hepatitis B Foundation Executive Director. "His personal and professional dedication to the prevention and control of hepatitis B and liver cancer will significantly advance our Foundation's mission to help all those affected."

Prior to joining the Foundation, Dr. Chen was a Research Associate and Project Manager for the Department of Epidemiology at the Drexel University School of Public Health in Philadelphia. He also served as a Senior Project Manager for the International Collaborative Research on Liver Cancer at Fox Chase Cancer Center in Philadelphia. During the 10-year international project, Dr. Chen helped develop and evaluate all field work protocols for the largest prospective cohort study of hepatitis B and liver cancer in the world.

Dr. Chen earned his M.D., M.S., and Ph.D., in Preventive Medicine and Epidemiology at Shanghai Medical University in China. He has served as a volunteer principal of the Guang Hua Chinese School in Philadelphia, volunteer president of the Fox Chase Cancer Center Chinese Scholars Association in Philadelphia, and volunteer consultant for the Haimen City Center for Disease Control and Prevention in China.

A member of the United States Tennis Association, Dr. Chen participates in tennis and table tennis matches. He is a resident of Warrington, Pa., and enjoys spending time with his wife and two children and volunteering at community events.

About The Hepatitis B Foundation

The Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure and improving the quality of life for those affected with hepatitis B worldwide through research, education and patient advocacy. The Foundation is located in the Pennsylvania Biotechnology Center, which it created to accelerate its research mission. For more information, please visit http://www.hepb.org or call (215) 489-4900.

# # #


Read more Press Releases from Leah Rice:
Other Press Release Headlines:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Leah Rice
The Hepatitis B Foundation

Senior Account Manager
2 Hidden Lane
Doylestown, PA
USA 18901
Voice: 215-340-0480
Fax: 215-340-0580
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.